HALO logo
halo search icon
002399
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A

002399 · Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A

9.04

CNY
-0.26 (-2.80%)
25/06/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

Yuan11.28B

PE

49.50

EV/EBITDA

19.6

DIV Yield

1.3%

Payout Ratio

64%

MQV Rating

5Very Weak

As at 25/06/2026 12:00:00 AM

Price Chart

Description

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. engages in the research, production and distribution of heparin sodium bulk drugs. It offers heparin sodium products including Food and Drug Administration (FDA) grade heparin sodium ingredients and ordinary grade heparin sodium ingredients. The company was founded by Li Tan, Li Li and Shan Yu on April 21, 1998 and is headquartered in Shenzhen, China.

  • All-Companies
  • All-Consensus
  • Consensus Expensive

Key Fundamentals

EPS 3 yr Growth

-52.00%

EBITDA Margin

16.20%

Operating Cashflow

¥1,731m

Free Cash Flow Return

13.50%

ROIC

2.70%

Interest Coverage

11.50

Quick Ratio

1.20

Performance

52 weeks range

Low 8.51 - 14.34

Trade Value (12mth)

US$2,092,331.00

1 week

-0.22%

1 month

-8.69%

YTD

-25.29%

1 year

-27.91%

All time high

188.88

Additional Data

Shares Outstanding (Fully Diluted)

1,467m

HALO Sector

N/A

Next Company Report Date

01-Apr-27

Next Ex Dividend Date

18-Jun-26

Next Dividend Pay Date

18-Jun-26

Reporting Currency

CNY

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A (002399:SHE)?
Halo FAQ
The current share price of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A (002399:SHE) is CNY¥9.04.
2
What is the 52-week high share price for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A (002399:SHE)?
Halo FAQ
The 52-week high share price for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A (002399:SHE) is CNY¥14.34.
3
What is the 52-week low share price for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A (002399:SHE)?
Halo FAQ
The 52-week low share price for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A (002399:SHE) is CNY¥8.51.
4
What is the dividend yield for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A (002399:SHE)?
Halo FAQ
The current TTM dividend payout for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A (002399:SHE) is 1.30.
5
What was Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A (002399:SHE) last dividend payment?
Halo FAQ
The last dividend payment of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A (002399:SHE) is CNY¥0.14.
6
What is the franking level for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A (002399:SHE)?
Halo FAQ
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A (002399:SHE) has a franking level of 0.00%.
7
What is the price-to-earnings (P/E) ratio for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A (002399:SHE)?
Halo FAQ
The current P/E ratio for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A (002399:SHE) is 49.50.